Multiple interacting gene products may influence susceptibility to malignant hyperthermia.
Malignant hyperthermia (MH) is a potentially lethal disorder triggered in susceptible individuals on exposure to common anaesthetic agents. Crises reflect the consequences of disturbed skeletal muscle calcium homeostasis. MH is an autosomal dominant, genetically heterogeneous trait. Defects in a single major gene have been assumed to determine susceptibility status in individual families. However, in some pedigrees phenotypic and genotypic data are discordant. One explanation, in contrast to the current genetic model, is that susceptibility is dependent upon the effects of more than one gene. Using the transmission disequilibrium test we assessed the involvement of 8 MH candidate loci (RYR1, CACNA1S, CACNA2D1, MHS4 at 3q13.1, MHS6 at 5p, LIPE, DM1, dystrophin) by analysis of data from 130 MH nuclear families. Results suggested that variations in more than one gene may influence MH susceptibility in single families.
Robinson
R L
RL
School of Biology,University of Leeds, UK. medrlr@stjames.leeds.ac.uk
Curran
J L
JL
Ellis
F R
FR
Halsall
P J
PJ
Hall
W J
WJ
Hopkins
P M
PM
Iles
D E
DE
West
S P
SP
Shaw
M A
MA
D018685:Anesthetics, Inhalation / Q000009:adverse effects; D020013:Calcium Signaling / Q000187:drug effects; D002877:Chromosomes, Human / Q000235:genetics; D005260:Female; D005819:Genetic Markers; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008305:Malignant Hyperthermia / Q000209:etiology / Q000235:genetics*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism; D010375:Pedigree; D010641:Phenotype
D018685:Anesthetics, Inhalation; D005819:Genetic Markers